Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.
Disc Medicine has raised $450.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2026.
Disc Medicine's investors include Wellington Management, Hercules Capital, TCG Crossover, Foresite Capital, Novo Holdings.
Disc Medicine is headquartered in Watertown, United States.
Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.
Disc Medicine is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Disc Medicine — Funding & Investors." VCBacked, October 20, 2026, https://www.vcbacked.co/company/disc-medicine. Accessed November 13, 2026.
VCBacked. (2026). Disc Medicine — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/disc-medicine
{{cite web |title=Disc Medicine — Funding & Investors |url=https://www.vcbacked.co/company/disc-medicine |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Disc Medicine? Request a listing update